NCT01386125View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)

PHASE3CompletedINTERVENTIONAL
Enrollment

748

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Nasal Polyps
Interventions
DRUG

Mometasone Furoate Nasal Spray (MFNS)

MFNS, 200 mcg BID administered as two 50 mcg sprays in each nostril BID for up to 16 weeks

DRUG

Placebo for MFNS

Two sprays in each nostril BID for up to 16 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01386125 - A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604) | Biotech Hunter | Biotech Hunter